$1.49
0.053.47%
In chiusura: -
$1.50
0.010.67%
After hour: 7:54 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Lexicon Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 6
EPS
$-0.040
Ricavi trimestrali
$14.18M
Ricavi annuali
(a partire da set 30)
(a partire da set 30)
$70.86M
Analizza lo storico degli utili di Lexicon Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
LXRX | Lexicon Pharmaceuticals | -$0.18 | -$0.07 | -$0.04 | 42.86% | $1.75M | $5.15M | $14.18M | 175.62% | 11/06/2025 | |
LXRX | Lexicon Pharmaceuticals | -$0.17 | -$0.08 | $0.01 | 112.50% | $1.65M | $5.52M | $28.87M | 423.27% | 08/06/2025 | |
LXRX | Lexicon Pharmaceuticals | -$0.20 | -$0.10 | -$0.07 | 30.00% | $1.13M | $2.12M | $1.26M | -40.47% | 05/13/2025 | |
LXRX | Lexicon Pharmaceuticals | -$0.20 | -$0.12 | -$0.09 | 25.00% | $702.00K | $6.48M | $26.55M | 309.78% | 03/06/2025 | |
LXRX | Lexicon Pharmaceuticals | -$0.21 | -$0.16 | -$0.18 | -12.50% | $162.00K | $2.93M | $1.75M | -40.27% | 11/12/2024 | |
LXRX | Lexicon Pharmaceuticals | -$0.22 | -$0.19 | -$0.17 | 10.53% | $317.00K | $2.83M | $1.65M | -41.80% | 08/01/2024 | |
LXRX | Lexicon Pharmaceuticals | -$0.17 | -$0.20 | -$0.20 | 0.00% | $24.00K | $1.37M | $1.13M | -17.52% | 05/02/2024 | |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.22 | -$0.20 | 9.09% | $28.00K | $1.24M | $702.00K | -43.39% | 03/11/2024 | |
LXRX | Lexicon Pharmaceuticals | -$0.13 | -$0.21 | -$0.21 | 0.00% | $39.00K | $2.06M | $162.00K | -92.14% | 11/08/2023 | |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.17 | -$0.22 | -29.41% | $35.00K | $70.00K | $317.00K | 352.86% | 08/03/2023 | |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.18 | -$0.17 | 5.56% | $37.00K | $30.00K | $24.00K | -20.00% | 05/02/2023 | |
LXRX | Lexicon Pharmaceuticals | -$0.17 | -$0.13 | -$0.16 | -23.08% | $14.00K | $50.00K | $28.00K | -44.00% | 03/02/2023 | |
LXRX | Lexicon Pharmaceuticals | -$0.16 | -$0.14 | -$0.13 | 7.14% | $23.00K | $50.00K | $39.00K | -22.00% | 11/09/2022 | |
LXRX | Lexicon Pharmaceuticals | -$0.13 | -$0.16 | -$0.16 | 0.00% | $234.00K | $50.00K | $35.00K | -30.00% | 08/02/2022 | |
LXRX | Lexicon Pharmaceuticals | -$0.15 | -$0.16 | -$0.16 | 0.00% | $27.00K | $50.00K | $37.00K | -26.00% | 05/05/2022 | |
LXRX | Lexicon Pharmaceuticals | -$0.04 | -$0.18 | -$0.17 | 5.56% | $199.00K | — | $14.00K | — | 02/28/2022 | |
LXRX | Lexicon Pharmaceuticals | -$0.43 | -$0.18 | -$0.16 | 11.11% | $6.63M | — | $23.00K | — | 11/03/2021 | |
LXRX | Lexicon Pharmaceuticals | -$0.65 | -$0.16 | -$0.13 | 18.75% | $9.16M | $10.00K | $234.00K | 2240.00% | 07/30/2021 | |
LXRX | Lexicon Pharmaceuticals | -$0.63 | -$0.16 | -$0.15 | 6.25% | $8.00M | $1.68M | $27.00K | -98.39% | 05/06/2021 | |
LXRX | Lexicon Pharmaceuticals | -$0.48 | -$0.28 | -$0.04 | 85.71% | $8.73M | $110.00K | $199.00K | 80.91% | 03/10/2021 |
Lexicon Pharmaceuticals (LXRX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.04 | $-0.07 | 42.9 % |
| Q2 | 2025-08-06 | $0.01 | $-0.08 | 112.5 % |
| Q1 | 2025-05-13 | $-0.07 | $-0.10 | 30.0 % |
| Q4 | 2025-03-06 | $-0.09 | $-0.12 | 25.0 % |
Lexicon Pharmaceuticals (LXRX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $14.18M | $5.15M | 175.6 % |
| Q2 | 2025-08-06 | $28.87M | $5.52M | 423.3 % |
| Q1 | 2025-05-13 | $1.26M | $2.12M | -40.5 % |
| Q4 | 2025-03-06 | $26.55M | $6.48M | 309.8 % |
FAQ
Quando Lexicon Pharmaceuticals (NASDAQ:LXRX) riporterà gli utili?
Lexicon Pharmaceuticals (LXRX) non ha ancora previsto report sulle performance. L'ultimo report sui risultati è stato pubblicato il novembre 6, 2025 per il Q3.
Quali sono stati gli ultimi utili per azione (EPS) di Lexicon Pharmaceuticals (NASDAQ:LXRX)?
Lexicon Pharmaceuticals (LXRX) non ha ancora in programma alcun report sugli utili. L'ultimo report sugli utili è stato pubblicato il novembre 6, 2025 per il Q3 e l'EPS effettivo è stato $-0.04, che superato la stima di $-0.07.
Quali sono state le entrate di Lexicon Pharmaceuticals (NASDAQ:LXRX)?
Lexicon Pharmaceuticals (LXRX) non ha ancora pianificato alcun report sugli utili. L'ultimo report sugli utili è stato pubblicato il novembre 6, 2025 per il Q3 e i ricavi effettivi sono stati $14.2M, che superato la stima di $5.1M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.